bioRxiv ScienceSearch

Biology subjects

Bradley, B.

Publications and source records attributed to Bradley, B..

2 recordsLinked to original sources

Powerful and Efficient Strategies for Genetic Association Testing of Symptom and Questionnaire Data in Psychiatric Genetic Studies

Genetic studies of psychiatric disorders often deal with phenotypes that are not directly measurable. Instead, researchers rely on multivariate symptom data from questionnaires and surveys like the PTSD Symptom Scale (PSS) and Beck Depression Inventory (BDI) to indirectly assess a latent phenotype of interest. Researchers subsequently collapse such multivariate questionnaire data into a univariate outcome to represent a surrogate for the latent phenotype. However, when a causal variant is only associated with a subset of collapsed symptoms, the effect will be challenging to detect using the univariate outcome. We describe a more powerful strategy for genetic association testing in this situation that jointly analyzes the original multivariate symptom data collectively using a statistical framework that compares similarity in multivariate symptom-scale data from questionnaires to similarity in common genetic variants across a gene. We use simulated data to demonstrate this strategy provides substantially increased power over standard approaches that collapse questionnaire data into a single surrogate outcome. We also illustrate our approach using GWAS data from the Grady Trauma Project and identify genes associated with BDI not identified using standard univariate techniques. The approach is computationally efficient, scales to genome-wide studies, and is applicable to correlated symptom data of arbitrary dimension (thereby aligning with National Institute of Mental Healths Research Domain Criteria).

genetics

1/f neural noise is a better predictor of schizophrenia than neural oscillations

Diagnosis and symptom severity in schizophrenia are associated with irregularities across neural oscillatory frequency bands, including theta, alpha, beta, and gamma. However, electroencephalographic signals consist of both periodic and aperiodic activity characterized by the (1/fX) shape in the power spectrum. In this paper we investigated oscillatory and aperiodic activity differences between patients with schizophrenia and healthy controls during a target detection task. Separation into periodic and aperiodic components revealed that the steepness of the power spectrum better predicted group status than traditional band-limited oscillatory power in a classification analysis. Aperiodic activity also outperformed the predictions made using participants behavioral responses. Additionally, the differences in aperiodic activity were highly consistent across all electrodes. In sum, compared to oscillations the aperiodic activity appears to be a more accurate and more robust way to differentiate patients with schizophrenia from healthy controls. Significance statementUnderstanding the neurobiological origins of schizophrenia and identifying reliable and consistent biomarkers are of critical importance to improving treatment of that disease. Numerous studies have reported disruptions to neural oscillations in patients with schizophrenia. This has, in part, led to schizophrenia being characterized as a disease of disrupted neural coordination, reflected by changes in frequency band power. We report however that changes in the aperiodic signal can also predict clinical status. Unlike band-limited power though, aperiodic activity predicts status better than participants own behavioral performance and acts as a consistent predictor across all electrodes. Alterations in the aperiodic signal are consistent with well-established inhibitory neuron dysfunctions associated with schizophrenia, allowing for a direct link between noninvasive EEG and chronic, widespread, neurobiological deficits.

neuroscience